4//SEC Filing
Powl Brian T. 4
Accession 0001209191-22-039819
CIK 0001434316other
Filed
Jun 28, 8:00 PM ET
Accepted
Jun 29, 5:02 PM ET
Size
7.4 KB
Accession
0001209191-22-039819
Insider Transaction Report
Form 4
Powl Brian T.
Chief Commercial Officer
Transactions
- Award
Common Stock
2022-06-27+45,000→ 45,000 total - Award
Stock Option (Right to Buy)
2022-06-27+70,000→ 70,000 totalExercise: $26.25Exp: 2032-06-27→ Common Stock (70,000 underlying)
Footnotes (2)
- [F1]Exempt grant of restricted stock units pursuant to the Issuer's Amended and Restated Inducement Equity Plan. 25% of the award will vest on July 1, 2023, and 25% of the remainder shall vest on July 1, 2024, July 1, 2025, and July 1, 2026, subject to the Reporting Person's continuous service to the Issuer as of each such vesting date.
- [F2]The option shall vest as to 25% of the underlying shares on June 27, 2023 and thereafter on a monthly basis for 36 additional months, subject to the Reporting Person's continuous service to the Issuer as of each such vesting date.
Documents
Issuer
FATE THERAPEUTICS INC
CIK 0001434316
Entity typeother
Related Parties
1- filerCIK 0001934232
Filing Metadata
- Form type
- 4
- Filed
- Jun 28, 8:00 PM ET
- Accepted
- Jun 29, 5:02 PM ET
- Size
- 7.4 KB